Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,002 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma.
Miallot R, Millet V, Roger A, Fenouil R, Tardivel C, Martin JC, Tranchida F, Shintu L, Berchard P, Sousa Lanza J, Malissen B, Henri S, Ugolini S, Dutour A, Finetti P, Bertucci F, Blay JY, Galland F, Naquet P. Miallot R, et al. Among authors: blay jy. Life Sci Alliance. 2023 Nov 29;7(2):e202302479. doi: 10.26508/lsa.202302479. Print 2024 Feb. Life Sci Alliance. 2023. PMID: 38030222 Free PMC article.
Therapeutic pipeline for soft-tissue sarcoma.
Cassier PA, Labidi-Galy SI, Heudel P, Dutour A, Méeus P, Chelghoum M, Alberti L, Ray-Coquard I, Blay JY. Cassier PA, et al. Among authors: blay jy. Expert Opin Pharmacother. 2011 Nov;12(16):2479-91. doi: 10.1517/14656566.2011.604633. Epub 2011 Sep 13. Expert Opin Pharmacother. 2011. PMID: 21913865 Review.
PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.
Bertucci F, Finetti P, Perrot D, Leroux A, Collin F, Le Cesne A, Coindre JM, Blay JY, Birnbaum D, Mamessier E. Bertucci F, et al. Among authors: blay jy. Oncoimmunology. 2017 Feb 8;6(3):e1278100. doi: 10.1080/2162402X.2016.1278100. eCollection 2017. Oncoimmunology. 2017. PMID: 28405501 Free PMC article.
Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial.
Kotecki N, Le Cesne A, Tresch-Bruneel E, Ray-Coquard I, Chevreau C, Bertucci F, Bogart E, Mir O, Pautier P, Decoupigny E, Clisant S, Blay JY, Penel N. Kotecki N, et al. Among authors: blay jy. Am J Clin Oncol. 2018 Nov;41(11):1094-1100. doi: 10.1097/COC.0000000000000430. Am J Clin Oncol. 2018. PMID: 29509592
Corrigendum to: ``The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target.'' J Bone Oncol. 2020 Feb; 20: 100271.
Richert I, Gomez-Brouchet A, Bouvier C, Du Bouexic De Pinieux G, KaranianM A, Blay JY, Dutour A. Richert I, et al. Among authors: blay jy. J Bone Oncol. 2020 Mar 16;22:100287. doi: 10.1016/j.jbo.2020.100287. eCollection 2020 Jun. J Bone Oncol. 2020. PMID: 32274326 Free PMC article.
1,002 results